News & Updates

Statin reduces the risk of cardiovascular disease and mortality in type 2 diabetes, and this beneficial effect is evident among middle-aged and, to a lesser extent, older patients but not among young patients, a study has found.

Selenium appears to reduce lipids and heighten the risk of type 2 diabetes (T2D), potentially via insulin resistance instead of pancreatic beta cell function, suggests a study.

Pheochromocytomas (PCC) and paragangliomas (PGL) show a wide range of symptoms, with frequent intraoperative instability despite good preoperative preparation, according to a Singapore study. In addition, up to one-fifth of the patients in a single centre developed disease recurrences and metastasis.

For patients with type 2 diabetes mellitus (T2DM), consumption of fruits and engagement in physical activity help cut the risk of death from all cause, cardiovascular disease (CVD), and stroke, as reported in a study.

A four-drug combination that includes either empagliflozin or dapagliflozin helps keep glucose in check through 3 years for patients with type 2 diabetes (T2D), in addition to its positive effect on weight and tolerable safety profile, as shown in an open-label randomized controlled study.